Skip to main content

ORACEA Capsules are precisely formulated for rapid and powerful results1

  • In a clinical study, results were seen as early as week 3 and continued through week 161
  • ORACEA Capsules can impact the inflammatory lesions of rosacea and did not induce bacterial resistance in a 9-month study

The precise formulation of ORACEA Capsules, 30 mg immediate-release and 10 mg delayed-release beads, provides:

  • Comparable efficacy to doxycycline 100 mg (an antibiotic dose)
  • No evidence of antimicrobial activity

ORACEA Capsules Efficacy

ORACEA Capsules are uniquely formulated for early and sustained efficacy in treating the inflammatory lesions associated with rosacea.

Learn More

ORACEA Capsules Tolerability

ORACEA Capusles are better tolerated than doxycycline 100 mg. Read about the favorable tolerability profile.

Learn More